nbhl / NBHL

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /nbhlhpwordpress/wp-admin/ Allow: /nbhlhpwordpress/wp-admin/admin-ajax.php Sitemap: https://nbhl.co.jp/nbhlhpwordpress/wp-sitemap.xml

Meta Tags

Title	NBHL
Description	Japanese Contact Access Home MENU Home About us Corporate overview Management team Scientific advisers Technologies GPCR Targeted Antibody Pipelines Overv
Keywords	N/A

Server Information

WebSite	nbhl.co.jp
Host IP	163.43.102.17
Location	Japan

さらに探索する

Site

invisalign-station.tokyo

nbhl.co.jp 評価

US$2,682,569

最終更新: 2022-10-01 17:48:07

nbhl.co.jp の Semrush グローバルランクは 3,945,586 です。nbhl.co.jp は、推定広告収入に基づいて、US$2,682,569 の推定価値を持っています。 nbhl.co.jp には、毎日約 309,528 人のユニークユーザーがアクセスしています。その Web サーバーは Japan にあり、IP アドレスは 163.43.102.17です。 SiteAdvisor によると、nbhl.co.jp は安全にアクセスできます。

トラフィック & 見積もりの価値

売買価格	US$2,682,569
毎日の広告収入	US$2,477
月間広告収入	US$74,287
年間広告収入	US$891,439
デイリーユニークビジター	20,636
注: トラフィックと収益の値はすべて推定値です。

DNS Records

Host	Type	TTL	Data
nbhl.co.jp.	A	3600	IP: 163.43.102.17
nbhl.co.jp.	NS	3600	NS Record: ns1.dns.ne.jp.
nbhl.co.jp.	NS	3600	NS Record: ns2.dns.ne.jp.
nbhl.co.jp.	MX	3600	MX Record: 10 nbhl.co.jp.

HtmlToTextCheckTime:2022-10-01 17:48:07

Japanese Contact Access Home MENU Home About us Corporate overview Management team Scientific advisers Technologies GPCR Targeted Antibody Pipelines Overview Respiratory diseases & Chronic inflammation CNS Disorders Partnering Co-development Technology alliance Welcome to NBHL NB Health Laboratory Co. Ltd. (NBHL) is a biotechnology company dedicated to discovering, developing and commercializing innovative medicines to treat respiratory diseases, chronic inflammation and central nervous system disorders. NBHL has expertise in the generation of functional antibodies targeting G protein-coupled receptors (GPCRs) and is pioneering a new field in GPCR-targeted drug discovery to benefit human health. News archives ALL Completion of the Series C funding to advance pipeline of novel GPCR antibodies Apr 27,2022 -- Updated 22:50 +0900 (GMT) NBHL has completed 7.64 million USD of the Series C funding to advance pipeline of novel GPCR antibodies. Click here for detail. Announcement of a grant of

HTTP Headers

HTTP/1.1 302 Moved Temporarily
Server: nginx
Date: Thu, 20 Jan 2022 09:01:56 GMT
Content-Type: text/html
Content-Length: 138
Connection: keep-alive
Location: https://nbhl.co.jp/

HTTP/2 200 
server: nginx
date: Thu, 20 Jan 2022 09:01:57 GMT
content-type: text/html; charset=UTF-8
x-powered-by: PHP/7.4.25
link: ; rel="https://api.w.org/"

nbhl.co.jp Whois Information

[ JPRS database provides information on network administration. Its use is    ]
[ restricted to network administration purposes. For further information,     ]
[ use 'whois -h whois.jprs.jp help'. To suppress Japanese output, add'/e'     ]
[ at the end of command, e.g. 'whois -h whois.jprs.jp xxx/e'.                 ]
Cannot process your search request.
Service currently unavailable due to incoming of a large amount of
requests.
Try again later.

nbhl.co.jp 評価と分析